Trials / Conditions / Total Parenteral Nutrition-induced Cholestasis

Total Parenteral Nutrition-induced Cholestasis

10 registered clinical trials studyying Total Parenteral Nutrition-induced Cholestasis.

Status	Trial	Sponsor	Phase
Completed	Compassionate Use of Omegaven in Children NCT02370251	University of Oklahoma	Phase 2 / Phase 3
Terminated	Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition NCT01565278	Johane Allard	Phase 3
Withdrawn	Compassionate Use of Omegaven IV Fat Emulsion NCT01323907	Sivan Kinberg	N/A
Completed	Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury NCT01845116	Wake Forest University Health Sciences	Phase 2
Terminated	Compassionate Use of Omegaven IV Fat Emulsion NCT00816348	Cindy Haller	Phase 2
Approved For Marketing	Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury i NCT02534077	Pediatrix	—
Approved For Marketing	Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury NCT01412359	Jeffrey Rudolph	—
Approved For Marketing	Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD NCT02929303	Wake Forest University Health Sciences	—
Approved For Marketing	Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children NCT02328768	University of Nebraska	—
Approved For Marketing	Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury NCT02780193	Rush University Medical Center	—